Abcam has appointed Peter Allen as non-executive Chairman with immediate effect. Peter assumes the role of Chairman from Louise Patten, who has been serving as interim Chairman and will revert to a non-executive Director. He has over 20 years’ experience as an executive director, non-executive director and Chairman in a wide range of life science companies. He is currently non-executive Chairman of AIM-listed companies Clinigen plc, Advanced Medical Solutions and Diurnal Group , as well as privately owned Oxford Nanopore Technologies Limited, and is also a non-executive director of privately owned Istesso Limited. From 1992-2004 Peter served as Chief Financial Officer of Celltech Group.